Lexicon Pharmaceuticals, Inc.NASDAQ: LXRX

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

· Issued by Lexicon Pharmaceuticals, Inc. via GlobeNewswire

Summary by 6ix AI

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company developing drug candidates in areas including neuropathic pain and obesity, said its management will present at three investor conferences in New York, NY, on September 9, 10 and 14, 2026.

Key details

  • Citi 2026 Biopharma Back to School Conference: September 9, 2026, 11:20–11:55 AM (Eastern Time).
  • 2026 Cantor Global Healthcare Conference: September 10, 2026, 3:20–3:50 PM (Eastern Time).
  • H.C. Wainwright 28th Annual Global Investment Conference: September 14, 2026, 9:00–9:30 AM (Eastern Time).
  • Live events and replays of the presentations can be accessed via the Events page on the company's investor website.

6ix AI wrote this summary from the release below and checked it against the release.

THE WOODLANDS, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management will present at three upcoming investor conferences taking place in New York, NY:

Citi 2026 Biopharma Back to School Conference
September 9, 2026, 11:20–11:55 AM (Eastern Time)

2026 Cantor Global Healthcare Conference
September 10, 2026, 3:20–3:50 PM (Eastern Time)

H.C. Wainwright 28th Annual Global Investment Conference
September 14, 2026, 9:00–9:30 AM (Eastern Time)

The live events and replays of the presentations can be accessed via the Events page on the company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals 
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.

For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
[email protected]

For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
[email protected]

Lexicon Pharmaceuticals, Inc. on 6ix

Story so far

Earlier from Lexicon Pharmaceuticals

Later from Lexicon Pharmaceuticals

All Lexicon Pharmaceuticals news releases